{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,2]],"date-time":"2026-03-02T19:54:04Z","timestamp":1772481244324,"version":"3.50.1"},"reference-count":111,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2012,2,1]],"date-time":"2012-02-01T00:00:00Z","timestamp":1328054400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Contact Lens and Anterior Eye"],"published-print":{"date-parts":[[2012,2]]},"DOI":"10.1016\/j.clae.2011.08.009","type":"journal-article","created":{"date-parts":[[2011,9,18]],"date-time":"2011-09-18T02:35:16Z","timestamp":1316313316000},"page":"9-16","source":"Crossref","is-referenced-by-count":32,"title":["A review of non-pharmacological and pharmacological management of seasonal and perennial allergic conjunctivitis"],"prefix":"10.1016","volume":"35","author":[{"given":"Paramdeep S.","family":"Bilkhu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James S.","family":"Wolffsohn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shehzad A.","family":"Naroo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.clae.2011.08.009_bib0005","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1016\/j.jaci.2007.11.004","article-title":"Is eczema really on the increase worldwide?","volume":"121","author":"Williams","year":"2008","journal-title":"Journal of Allergy and Clinical Immunology"},{"issue":"9537","key":"10.1016\/j.clae.2011.08.009_bib0010","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1016\/S0140-6736(06)69283-0","article-title":"Worldwide time trends in the prevalence of symptoms of asthma, allergic rhinoconjunctivitis, and eczema in childhood: ISAAC Phases One and Three repeat multi-country cross-sectional surveys","volume":"368","author":"Asher","year":"2006","journal-title":"The Lancet"},{"issue":"4","key":"10.1016\/j.clae.2011.08.009_bib0015","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1177\/146642400512500410","article-title":"Allergic rhinitis: an update","volume":"125","author":"Savage","year":"2005","journal-title":"Journal of the Royal Society for the Promotion of Health"},{"issue":"3","key":"10.1016\/j.clae.2011.08.009_bib0020","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1111\/j.1365-2567.2004.01925.x","article-title":"The increased prevalence of allergy and the hygiene hypothesis: missing immune deviation, reduced immune suppression, or both?","volume":"112","author":"Romagnani","year":"2004","journal-title":"Immunology"},{"issue":"10","key":"10.1016\/j.clae.2011.08.009_bib0025","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1136\/jech.2003.019182","article-title":"Infections, medication use, and the prevalence of symptoms of asthma, eczema and rhinitis in childhood","volume":"58","author":"Cohet","year":"2004","journal-title":"Journal of Epidemiology and Community Health"},{"key":"10.1016\/j.clae.2011.08.009_bib0030","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1097\/01.all.0000162307.89857.88","article-title":"The hygiene hypothesis: does it function worldwide?","volume":"5","author":"Bresciani","year":"2005","journal-title":"Current Opinion in Allergy and Clinical Immunology"},{"issue":"8","key":"10.1016\/j.clae.2011.08.009_bib0035","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1034\/j.1398-9995.2000.00672.x","article-title":"The prevalence of skin-test-positive allergic rhinitis in Danish adults: two cross-sectional surveys 8 years apart. The Copenhagen Allergy Study","volume":"55","author":"Linneberg","year":"2000","journal-title":"Allergy"},{"issue":"9","key":"10.1016\/j.clae.2011.08.009_bib0040","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1111\/j.1398-9995.2007.01393.x","article-title":"Allergenic pollen and pollen allergy in Europe","volume":"62","author":"D\u2019Amato","year":"2007","journal-title":"Allergy"},{"issue":"3","key":"10.1016\/j.clae.2011.08.009_bib0045","first-page":"238","article-title":"Airborne plane-trees (platanus hispanica) pollen distribution in the city of Cordoba, south western Spain, and possible implications on pollen allergy","volume":"14","author":"Alcazar","year":"2004","journal-title":"Journal of Investigative Allergology and Clinical Immunology"},{"issue":"4","key":"10.1016\/j.clae.2011.08.009_bib0050","first-page":"74","article-title":"The mechanisms, diagnosis and treatment of allergy","volume":"9","author":"Abelson","year":"2002","journal-title":"Review of Ophthalmology"},{"issue":"3","key":"10.1016\/j.clae.2011.08.009_bib0055","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1517\/14728214.10.3.505","article-title":"Emerging drugs for ocular allergy","volume":"10","author":"Leonardi","year":"2005","journal-title":"Expert Opinion on Emerging Drugs"},{"key":"10.1016\/j.clae.2011.08.009_bib0060","unstructured":"Wolffsohn JS, Naroo SA, Gupta N, Emberlin J. Prevalence and impact of ocular allergy in the population attending UK optometric practice. Contact Lens and Anterior Eye, in press."},{"issue":"S","key":"10.1016\/j.clae.2011.08.009_bib0065","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/0039-6257(93)90036-7","article-title":"Conjunctivitis of allergic origin: immunologic mechanisms and current approaches to therapy","volume":"38","author":"Abelson","year":"1993","journal-title":"Survey of Opthalmology"},{"issue":"S","key":"10.1016\/j.clae.2011.08.009_bib0070","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/0039-6257(93)90035-6","article-title":"Conjunctivitis of allergic origin: clinical presentation and differential diagnosis","volume":"38","author":"Friedlaender","year":"1993","journal-title":"Survey of Ophthalmology"},{"issue":"6","key":"10.1016\/j.clae.2011.08.009_bib0075","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1067\/mai.2000.111238","article-title":"Allergic and immunologic disorders of the eye Part II: ocular allergy","volume":"106","author":"Bielory","year":"2000","journal-title":"Journal of Allergy and Clinical Immunology"},{"issue":"2","key":"10.1016\/j.clae.2011.08.009_bib0080","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/0039-6257(79)90125-5","article-title":"Adverse external effects of topical ophthalmic medications","volume":"24","author":"Wilson","year":"1979","journal-title":"Survey of Ophthalmology"},{"issue":"2","key":"10.1016\/j.clae.2011.08.009_bib0085","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/S0149-2918(00)88478-7","article-title":"Antiglaucoma medications: a review of safety and tolerability issues related to their use","volume":"22","author":"Schuman","year":"2000","journal-title":"Clinical Therapeutics"},{"issue":"3","key":"10.1016\/j.clae.2011.08.009_bib0090","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.reval.2011.01.045","article-title":"Contact allergic reactions on the eyes and eyelids","volume":"51","author":"Collet","year":"2011","journal-title":"Revue Francaise D Allergologie"},{"issue":"3","key":"10.1016\/j.clae.2011.08.009_bib0095","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/0039-6257(93)90076-J","article-title":"Ocular tuberculosis","volume":"38","author":"Helm","year":"1993","journal-title":"Survey of Ophthalmology"},{"issue":"1","key":"10.1016\/j.clae.2011.08.009_bib0100","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.iac.2007.11.001","article-title":"Giant papillary conjunctivitis","volume":"28","author":"Donshik","year":"2008","journal-title":"Immunology and Allergy Clinics of North America"},{"issue":"1","key":"10.1016\/j.clae.2011.08.009_bib0105","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.iac.2007.12.001","article-title":"Ocular allergy treatment","volume":"28","author":"Bielory","year":"2008","journal-title":"Immunology and Allergy Clinics of North America"},{"key":"10.1016\/j.clae.2011.08.009_bib0110","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1027\/0838-1925.19.S1.4","article-title":"Allergic conjunctivitis","volume":"19","author":"Cox","year":"2007","journal-title":"Allergy and Clinical Immunology International-Journal of the World Allergy Organisation"},{"issue":"4","key":"10.1016\/j.clae.2011.08.009_bib0115","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1007\/s11882-009-0042-1","article-title":"Ocular allergic disorders: disease entities and differential diagnoses","volume":"9","author":"Berdy","year":"2009","journal-title":"Current Allergy and Asthma Reports"},{"issue":"1","key":"10.1016\/j.clae.2011.08.009_bib0120","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.iac.2007.12.011","article-title":"Ocular allergy overview","volume":"28","author":"Bielory","year":"2008","journal-title":"Immunology and Allergy Clinics of North America"},{"issue":"4","key":"10.1016\/j.clae.2011.08.009_bib0125","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1038\/sj.eye.6700675","article-title":"Vernal keratoconjunctivitis","volume":"18","author":"Bonini","year":"2004","journal-title":"Eye"},{"issue":"6","key":"10.1016\/j.clae.2011.08.009_bib0130","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.clae.2009.08.002","article-title":"The management of allergic eye disease in primary care","volume":"32","author":"Chigbu","year":"2009","journal-title":"Contact Lens and Anterior Eye"},{"issue":"6","key":"10.1016\/j.clae.2011.08.009_bib0135","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1046\/j.1365-2222.1998.0280s6039.x","article-title":"Allergic eye disease \u2013 a clinical challenge","volume":"28","author":"Buckley","year":"1998","journal-title":"Clinical and Experimental Allergy"},{"issue":"1","key":"10.1016\/j.clae.2011.08.009_bib0140","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.mcna.2005.08.013","article-title":"Allergic diseases of the eye","volume":"90","author":"Bielory","year":"2006","journal-title":"Medical Clinics of North America"},{"issue":"1","key":"10.1016\/j.clae.2011.08.009_bib0145","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1076\/opep.11.1.17.26437","article-title":"Economic and quality of life impact of seasonal allergic conjunctivitis in Oxfordshire","volume":"11","author":"Pitt","year":"2004","journal-title":"Ophthalmic Epidemiology"},{"issue":"4","key":"10.1016\/j.clae.2011.08.009_bib0150","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1080\/09286580590967781","article-title":"The economic and quality of life impact of seasonal allergic conjunctivitis in Spanish setting","volume":"12","author":"Smith","year":"2005","journal-title":"Ophthalmic Epidemiology"},{"issue":"2","key":"10.1016\/j.clae.2011.08.009_bib0155","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1177\/112067211002000201","article-title":"Allergic conjunctivitis: a national cross-sectional study of clinical characteristics and quality of life","volume":"20","author":"Palmares","year":"2010","journal-title":"European Journal of Ophthalmology"},{"issue":"2","key":"10.1016\/j.clae.2011.08.009_bib0160","doi-asserted-by":"crossref","first-page":"208","DOI":"10.2165\/00003495-199550020-00002","article-title":"Therapeutic options in ocular allergic disease","volume":"50","author":"Hingorani","year":"1995","journal-title":"Drugs"},{"issue":"3","key":"10.1016\/j.clae.2011.08.009_bib0165","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1358\/dot.1998.34.3.485181","article-title":"Seasonal allergic conjunctivitis","volume":"34","author":"Joss","year":"1998","journal-title":"Drugs of Today"},{"issue":"5","key":"10.1016\/j.clae.2011.08.009_bib0170","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1097\/ACI.0b013e32833dfa28","article-title":"Treatment of seasonal allergic conjunctivitis with ophthalmic corticosteroids: in search of the perfect ocular corticosteroids in the treatment of allergic conjunctivitis","volume":"10","author":"Bielory","year":"2010","journal-title":"Current Opinion in Allergy and Clinical Immunology"},{"issue":"5","key":"10.1016\/j.clae.2011.08.009_bib0175","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1067\/mai.2000.110930","article-title":"Tear and conjunctival changes during the allergen-induced early- and late-phase responses","volume":"106","author":"Bacon","year":"2000","journal-title":"Journal of Allergy and Clinical Immunology"},{"issue":"5","key":"10.1016\/j.clae.2011.08.009_bib0180","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1097\/ACI.0b013e32830e6b3a","article-title":"Late-phase reaction in ocular allergy","volume":"8","author":"Choi","year":"2008","journal-title":"Current Opinion in Allergy and Clinical Immunology"},{"issue":"1","key":"10.1016\/j.clae.2011.08.009_bib0185","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.jaci.2004.10.042","article-title":"Allergic conjunctivitis: update on pathophysiology and prospects for future treatment","volume":"115","author":"Ono","year":"2005","journal-title":"Journal of Allergy and Clinical Immunology"},{"issue":"5","key":"10.1016\/j.clae.2011.08.009_bib0190","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1097\/ACI.0b013e3282ef6937","article-title":"Classification of ocular allergy","volume":"7","author":"Hodges","year":"2007","journal-title":"Current Opinion in Allergy and Clinical Immunology"},{"key":"10.1016\/j.clae.2011.08.009_bib0195","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1111\/j.1365-2249.2008.03716.x","article-title":"Allergy and the eye","volume":"153","author":"Leonardi","year":"2008","journal-title":"Clinical and Experimental Immunology"},{"issue":"4","key":"10.1016\/j.clae.2011.08.009_bib0200","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1007\/s11882-002-0062-6","article-title":"Pathophysiology of ocular allergy: the roles of conjunctival mast cells and epithelial cells","volume":"2","author":"Stahl","year":"2002","journal-title":"Current Allergy and Asthma Reports"},{"key":"10.1016\/j.clae.2011.08.009_bib0205","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1159\/000234769","article-title":"Conjunctival provocation test as a model for the study of allergy and inflammation in humans","volume":"88","author":"Bonini","year":"1989","journal-title":"International Archives of Allergy and Applied Immunology"},{"issue":"5","key":"10.1016\/j.clae.2011.08.009_bib0210","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1007\/BF03259334","article-title":"Management of allergic conjunctivitis","volume":"5","author":"Ciprandi","year":"1996","journal-title":"Clinical Immunotherapeutics"},{"issue":"4","key":"10.1016\/j.clae.2011.08.009_bib0215","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1007\/s11882-001-0051-1","article-title":"Overview of ocular allergy treatment","volume":"1","author":"Friedlaender","year":"2001","journal-title":"Current Allergy and Asthma Reports"},{"issue":"227","key":"10.1016\/j.clae.2011.08.009_bib0220","first-page":"22","article-title":"Managing the contact lens wearing allergy sufferer","volume":"5950","author":"Veys","year":"2004","journal-title":"Optician"},{"issue":"6","key":"10.1016\/j.clae.2011.08.009_bib0225","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1111\/j.1398-9995.2008.01690.x","article-title":"House dust mite control measures for asthma: systematic review","volume":"63","author":"Gotzche","year":"2008","journal-title":"Allergy"},{"key":"10.1016\/j.clae.2011.08.009_bib0230","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD001563.pub3","article-title":"House dust mite avoidance measures for perennial allergic rhinitis","volume":"7","author":"Sheikh","year":"2010","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"6","key":"10.1016\/j.clae.2011.08.009_bib0235","doi-asserted-by":"crossref","first-page":"289","DOI":"10.2500\/108854192778816942","article-title":"Management of allergies to animals","volume":"13","author":"Eggleston","year":"1992","journal-title":"Asthma Proceedings"},{"issue":"6","key":"10.1016\/j.clae.2011.08.009_bib0240","doi-asserted-by":"crossref","first-page":"575","DOI":"10.2500\/aap.2008.29.3172","article-title":"Indoor allergens, environmental avoidance and allergic respiratory disease","volume":"29","author":"Bush","year":"2008","journal-title":"Allergy and Asthma Proceedings"},{"issue":"2","key":"10.1016\/j.clae.2011.08.009_bib0245","doi-asserted-by":"crossref","first-page":"118","DOI":"10.2174\/187221309788489733","article-title":"Seasonal and perennial allergic conjunctivitis","volume":"3","author":"Wong","year":"2009","journal-title":"Recent Patents on Inflammation and Allergy Drugs Discovery"},{"issue":"5","key":"10.1016\/j.clae.2011.08.009_bib0250","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1097\/01.all.0000244801.79475.66","article-title":"Pharmacology of ocular allergy","volume":"6","author":"Schultz","year":"2006","journal-title":"Current Opinion in Allergy and Clinical Immunology"},{"issue":"10","key":"10.1016\/j.clae.2011.08.009_bib0255","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1111\/j.1365-2222.1992.tb02066.x","article-title":"Double blind group comparative study of 2-percent nedocromil sodium eye drops with 2-percent sodium cromoglycate and placebo eye drops in the treatment of seasonal allergic conjunctivitis","volume":"22","author":"Leino","year":"1992","journal-title":"Clinical and Experimental Allergy"},{"issue":"1","key":"10.1016\/j.clae.2011.08.009_bib0260","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/S0002-9394(14)75754-X","article-title":"Efficacy and safety of nedocromil sodium ophthalmic solution in the treatment of seasonal allergic conjunctivitis","volume":"113","author":"Blumenthal","year":"1992","journal-title":"American Journal of Ophthalmology"},{"issue":"2","key":"10.1016\/j.clae.2011.08.009_bib0265","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1159\/000236823","article-title":"Lodoxamide treatment of allergic conjunctivitis","volume":"105","author":"Cerqueti","year":"1994","journal-title":"International Archives of Allergy and Immunology"},{"issue":"503","key":"10.1016\/j.clae.2011.08.009_bib0270","first-page":"451","article-title":"Topical treatments for allergic conjunctivitis: systematic review and meta-analysis of efficacy and effectiveness","volume":"54","author":"Owen","year":"2004","journal-title":"British Journal of General Practice"},{"key":"10.1016\/j.clae.2011.08.009_bib0275","unstructured":"BMJ Group and Pharmaceutical Press. British National Formulary 61. 11. Eye. 11.4 Corticosteroids and other anti-inflammatory preparations; 2010. Available from: www.bnf.org [accessed 11.04.2011]."},{"issue":"1","key":"10.1016\/j.clae.2011.08.009_bib0280","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/0091-6749(94)90069-8","article-title":"Sodium cromoglycate eye drops: regular versus as needed use in seasonal allergic conjunctivitis","volume":"94","author":"Juniper","year":"1994","journal-title":"Journal of Allergy and Clinical Immunology"},{"key":"10.1016\/j.clae.2011.08.009_bib0285","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1177\/112067219200200306","article-title":"Randomised double masked trial of lodoxamide and sodium cromoglycate in allergic eye disease","volume":"2","author":"Fahy","year":"1992","journal-title":"European Journal of Ophthalmology"},{"issue":"3","key":"10.1016\/j.clae.2011.08.009_bib0290","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1007\/BF00160774","article-title":"Twice daily 4% sodium cromoglycate vs 2% sodium cromoglycate used four times daily in seasonal (grass pollen) allergic conjunctivitis","volume":"82","author":"Collum","year":"1992","journal-title":"Documenta Ophthalmologica"},{"issue":"5","key":"10.1016\/j.clae.2011.08.009_bib0295","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1097\/01.all.0000183113.63311.11","article-title":"Histamine receptors and the conjunctiva","volume":"5","author":"Bielory","year":"2005","journal-title":"Current Opinion in Allergy and Clinical immunology"},{"issue":"2","key":"10.1016\/j.clae.2011.08.009_bib0300","first-page":"81","article-title":"Antazoline phosphate and naphazoline hydrochloride, singly and in combination for the treatment of allergic conjunctivitis \u2013 a controlled, double blind clinical trial","volume":"35","author":"Miller","year":"1975","journal-title":"Annals of Allergy"},{"issue":"2","key":"10.1016\/j.clae.2011.08.009_bib0305","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1111\/j.1365-2222.1997.tb00691.x","article-title":"Azelastine eye drops reduce and prevent allergic conjunctival reaction and exert anti-allergic activity","volume":"27","author":"Ciprandi","year":"1997","journal-title":"Clinical and Experimental Allergy"},{"issue":"9","key":"10.1016\/j.clae.2011.08.009_bib0310","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1111\/j.1398-9995.1998.tb03991.x","article-title":"Azelastine eye drops in seasonal allergic conjunctivitis or rhinoconjunctivitis \u2013 a double blind, randomised, placebo-controlled study","volume":"53","author":"Giede-Tuch","year":"1998","journal-title":"Allergy"},{"issue":"6","key":"10.1016\/j.clae.2011.08.009_bib0315","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/S0002-9394(00)00689-9","article-title":"Emedastine ophthalmic solution 0.05% versus levocabastine ophthalmic suspension 0.05% in the treatment of allergic conjunctivitis in the conjunctival allergen challenge model","volume":"130","author":"Netland","year":"2000","journal-title":"American Journal of Ophthalmology"},{"key":"10.1016\/j.clae.2011.08.009_bib0320","doi-asserted-by":"crossref","first-page":"993","DOI":"10.2147\/OPTH.S13479","article-title":"Azelastine hydrochloride, a dual acting anti-inflammatory ophthalmic solution, for treatment of allergic conjunctivitis","volume":"4","author":"Williams","year":"2010","journal-title":"Clinical Ophthalmology"},{"issue":"4","key":"10.1016\/j.clae.2011.08.009_bib0325","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1185\/030079903125001794","article-title":"Topical azelastine in perennial allergic conjunctivitis","volume":"19","author":"Canonica","year":"2003","journal-title":"Current Medical Research and Opinion"},{"issue":"2","key":"10.1016\/j.clae.2011.08.009_bib0330","doi-asserted-by":"crossref","first-page":"215","DOI":"10.2165\/00003495-200565020-00004","article-title":"Efficacy and tolerability of newer antihistamines in the treatment of allergic conjunctivitis","volume":"65","author":"Bielory","year":"2005","journal-title":"Drugs"},{"key":"10.1016\/j.clae.2011.08.009_bib0335","unstructured":"The electronic Medicines Compendium (eMC). Optrex bloodshot eye drops \u2013 summary of product characteristics (SPC); 2010. Available from: http:\/\/www.medicines.org.uk\/EMC\/medicine\/23394\/SPC\/Optrex+Bloodshot+Eye+Drops\/ [accessed 11.04.11]."},{"issue":"2","key":"10.1016\/j.clae.2011.08.009_bib0340","doi-asserted-by":"crossref","first-page":"141","DOI":"10.3109\/02713688208997687","article-title":"Treatment of allergic conjunctivitis with ocular decongestants","volume":"2","author":"Smith","year":"1982","journal-title":"Current Eye Research"},{"issue":"3","key":"10.1016\/j.clae.2011.08.009_bib0345","first-page":"174","article-title":"A double masked comparison of ocular decongestants as therapy for allergic conjunctivitis","volume":"50","author":"Lanier","year":"1983","journal-title":"Annals of Allergy"},{"issue":"4","key":"10.1016\/j.clae.2011.08.009_bib0350","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1001\/archopht.1990.01070060068051","article-title":"Effects of vasocon-A in the allergen challenge model of acute allergic conjunctivitis","volume":"108","author":"Abelson","year":"1990","journal-title":"Archives of Ophthalmology"},{"key":"10.1016\/j.clae.2011.08.009_bib0355","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/S0002-9394(14)74864-0","article-title":"Effects of topically applied ocular decongestant and antihistamine","volume":"90","author":"Abelson","year":"1980","journal-title":"American Journal of Ophthalmology"},{"issue":"11","key":"10.1016\/j.clae.2011.08.009_bib0360","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.2165\/00003495-200262110-00004","article-title":"Ocular allergy guidelines \u2013 a practical treatment algorithm","volume":"62","author":"Bielory","year":"2002","journal-title":"Drugs"},{"key":"10.1016\/j.clae.2011.08.009_bib0365","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/S0002-9343(02)01435-3","article-title":"Role of antihistamines in ocular allergy","volume":"113","author":"Bielory","year":"2002","journal-title":"American Journal of Medicine"},{"issue":"4","key":"10.1016\/j.clae.2011.08.009_bib0370","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/j.clinthera.2007.03.017","article-title":"An open label, investigator-masked, crossover study of the ocular drying effects of two antihistamines, topical epinastine and systemic loratadine, in adult volunteers with seasonal allergic conjunctivitis","volume":"29","author":"Ousler","year":"2007","journal-title":"Clinical Therapeutics"},{"issue":"3","key":"10.1016\/j.clae.2011.08.009_bib0375","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/S0149-2918(02)85045-7","article-title":"A randomized, double-blind, placebo-controlled comparison of emedastine 0.05% ophthalmic solution with loratadine 10mg and their combination in the human conjunctival allergen challenge model","volume":"24","author":"Abelson","year":"2002","journal-title":"Clinical Therapeutics"},{"issue":"7","key":"10.1016\/j.clae.2011.08.009_bib0380","doi-asserted-by":"crossref","first-page":"1975","DOI":"10.1016\/S0149-2918(03)80199-6","volume":"25","author":"Crampton","year":"2003","journal-title":"Clinical Therapeutics"},{"issue":"6","key":"10.1016\/j.clae.2011.08.009_bib0385","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1016\/S1081-1206(10)62292-2","article-title":"Olopatadine ophthalmic solution adjunctive to loratadine compared with loratadine alone in patients with active seasonal allergic conjunctivitis symptoms","volume":"86","author":"Lanier","year":"2001","journal-title":"Annals of Allergy Asthma and Immunology"},{"issue":"3","key":"10.1016\/j.clae.2011.08.009_bib0390","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/S1081-1206(10)62814-1","article-title":"Evaluation of olopatadine, a new ophthalmic antiallergic agent with dual activity, using the conjunctival allergen challenge model","volume":"81","author":"Abelson","year":"1998","journal-title":"Annals of Allergy Asthma and Immunology"},{"issue":"9","key":"10.1016\/j.clae.2011.08.009_bib0395","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1016\/j.clinthera.2005.09.013","article-title":"Comparison of the effects of ketotifen fumarate 0.025% and olopatadine HCl 0.1% ophthalmic solutions in seasonal allergic conjunctivitis: a 30-day, randomized, double-masked, artificial tear substitute-controlled trial","volume":"27","author":"Avunduk","year":"2005","journal-title":"Clinical Therapeutics"},{"issue":"10","key":"10.1016\/j.clae.2011.08.009_bib0400","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1136\/bjo.87.10.1206","article-title":"Efficacy and safety of ketotifen eye drops in the treatment of seasonal allergic conjunctivitis","volume":"87","author":"Kidd","year":"2003","journal-title":"British Journal of Ophthalmology"},{"issue":"1","key":"10.1016\/j.clae.2011.08.009_bib0405","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/S0149-2918(04)90004-5","article-title":"Efficacy and tolerability of ophthalmic epinastine assessed using the conjunctival antigen challenge model in patients with a history of allergic conjunctivitis","volume":"26","author":"Abelson","year":"2004","journal-title":"Clinical Therapeutics"},{"issue":"5","key":"10.1016\/j.clae.2011.08.009_bib0410","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1080\/09286580701299411","article-title":"Topical non-steroidal anti-inflammatory drugs in allergic conjunctivitis: meta-analysis of randomized trial data","volume":"14","author":"Swamy","year":"2007","journal-title":"Ophthalmic Epidemiology"},{"issue":"2","key":"10.1016\/j.clae.2011.08.009_bib0415","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1089\/jop.1998.14.137","article-title":"A multicenter comparison of the ocular efficacy and safety of diclofenac 0.1% solution with that of ketorolac 0.5% solution in patients with acute seasonal allergic conjunctivitis","volume":"14","author":"Tauber","year":"1998","journal-title":"Journal of Ocular Pharmacology and Therapeutics"},{"issue":"3","key":"10.1016\/j.clae.2011.08.009_bib0420","first-page":"212","article-title":"Management of ocular allergy","volume":"75","author":"Friedlaender","year":"1995","journal-title":"Annals of Allergy Asthma and Immunology"},{"issue":"1","key":"10.1016\/j.clae.2011.08.009_bib0425","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.iac.2007.12.005","article-title":"Allergic conjunctivitis","volume":"28","author":"Bielory","year":"2008","journal-title":"Immunology and Allergy Clinics of North America"},{"issue":"2","key":"10.1016\/j.clae.2011.08.009_bib0430","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/S0091-6749(98)70094-6","article-title":"A randomized, double-masked, placebo-controlled parallel study of 0.2% loteprednol etabonate in patients with seasonal allergic conjunctivitis","volume":"102","author":"Dell","year":"1998","journal-title":"Journal of Allergy and Clinical Immunology"},{"issue":"4","key":"10.1016\/j.clae.2011.08.009_bib0435","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1089\/jop.2008.0103","article-title":"A large, prospective observational study of novel cyclosporine 0.1% aqueous ophthalmic solution in the treatment of severe allergic conjunctivitis","volume":"25","author":"Ebihara","year":"2009","journal-title":"Journal of Ocular Pharmacology and Therapeutics"},{"issue":"6","key":"10.1016\/j.clae.2011.08.009_bib0440","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1016\/j.ophtha.2007.07.025","article-title":"Therapeutic effects of tacrolimus ointment for refractory ocular surface inflammatory diseases","volume":"115","author":"Miyazaki","year":"2008","journal-title":"Ophthalmology"},{"issue":"8","key":"10.1016\/j.clae.2011.08.009_bib0445","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1034\/j.1398-9995.1999.00077.x","article-title":"Sublingual-swallow immunotherapy (SLIT) with a standardised five-grass-pollen extract (drops and sublingual tablets) versus placebo in seasonal rhinitis","volume":"54","author":"Pradalier","year":"1999","journal-title":"Allergy"},{"issue":"5","key":"10.1016\/j.clae.2011.08.009_bib0450","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1097\/00130832-200210000-00013","article-title":"Current opinion on immunotherapy for ocular allergy","volume":"2","author":"Bielory","year":"2002","journal-title":"Current Opinion in Allergy and Clinical Immunology"},{"issue":"3","key":"10.1016\/j.clae.2011.08.009_bib0455","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1016\/j.jaci.2009.12.931","article-title":"Sublingual immunotherapy in patients with allergic rhinoconjunctivitis caused by ragweed pollen","volume":"125","author":"Skoner","year":"2010","journal-title":"Journal of Allergy and Clinical Immunology"},{"issue":"3","key":"10.1016\/j.clae.2011.08.009_bib0460","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/S0896-1549(03)00049-X","article-title":"Contact lenses and associated anterior segment disorders: dry eye, blepharitis and allergy","volume":"16","author":"Lemp","year":"2003","journal-title":"Ophthalmology Clinics of North America"},{"issue":"4","key":"10.1016\/j.clae.2011.08.009_bib0465","first-page":"77","article-title":"A menu of lens wear options for allergy prone patients","volume":"137","author":"Krohn","year":"2000","journal-title":"Review of Optometry"},{"key":"10.1016\/j.clae.2011.08.009_bib0470","unstructured":"Wolffsohn JS, Emberlin JC. Role of contact lenses in relieving ocular allergy. Contact Lens and Anterior Eye, in press."},{"issue":"5","key":"10.1016\/j.clae.2011.08.009_bib0475","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1097\/ACI.0b013e32830e6adc","article-title":"Contact lenses and allergy","volume":"8","author":"Lemp","year":"2008","journal-title":"Current Opinion in Allergy and Clinical Immunology"},{"issue":"4","key":"10.1016\/j.clae.2011.08.009_bib0480","first-page":"69","article-title":"Drops to prevent drop outs","volume":"137","author":"Shovlin","year":"2000","journal-title":"Review of Optometry"},{"key":"10.1016\/j.clae.2011.08.009_bib0485","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1097\/01.ICL.0000063576.32087.F7","article-title":"Evaluation of comfort using olopatadine hydrochloride 0.1% ophthalmic solution in the treatment of allergic conjunctivitis in contact lens wearers compared to placebo using the conjunctival allergen challenge model","volume":"29","author":"Brodsky","year":"2003","journal-title":"Eye and Contact Lens"},{"issue":"5","key":"10.1016\/j.clae.2011.08.009_bib0490","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1111\/j.1755-3768.2008.01265.x","article-title":"Efficacy of olopatadine HCI 0.1%, ketotifen fumarate 0.025%, epinastine HCI 0.05%, emedastine 0.05% and fluorometholone acetate 0.1% ophthalmic solutions for seasonal allergic conjunctivitis: a placebo-controlled environmental trial","volume":"87","author":"Borazan","year":"2009","journal-title":"Acta Ophthalmologica"},{"issue":"8","key":"10.1016\/j.clae.2011.08.009_bib0495","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1185\/030079904125004330","article-title":"Clinical efficacy of olopatadine vs epinastine ophthalmic solution in the conjunctival allergen challenge model","volume":"20","author":"Lanier","year":"2004","journal-title":"Current Medical Research and Opinion"},{"issue":"6","key":"10.1016\/j.clae.2011.08.009_bib0500","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1185\/030079907X188206","article-title":"Efficacy and comfort of olopatadine 0.2% versus epinastine 0.05% ophthalmic solution for treating itching and redness induced by conjunctival allergen challenge","volume":"23","author":"Mah","year":"2007","journal-title":"Current Medical Research and Opinion"},{"issue":"4","key":"10.1016\/j.clae.2011.08.009_bib0505","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1007\/s11882-003-0100-z","article-title":"Conjunctival allergen challenge: models in the investigation of ocular allergy","volume":"3","author":"Abelson","year":"2003","journal-title":"Current Allergy and Asthma Reports"},{"issue":"5","key":"10.1016\/j.clae.2011.08.009_bib0510","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1097\/00130832-200210000-00008","article-title":"Conjunctival provocation testing: overview of recent clinical trials in ocular allergy","volume":"2","author":"Friedlaender","year":"2002","journal-title":"Current Opinion in Allergy and Clinical Immunology"},{"issue":"3","key":"10.1016\/j.clae.2011.08.009_bib0515","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/S1542-0124(12)70196-9","article-title":"Methodologies for the study of ocular surface disease","volume":"3","author":"Ousler","year":"2005","journal-title":"Ocular Surface"},{"issue":"8","key":"10.1016\/j.clae.2011.08.009_bib0520","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1016\/S0149-2918(01)80106-5","article-title":"Evaluation of the efficacy of olopatadine hydrochloride 0.1% ophthalmic solution and azelastine hydrochloride 0.05% ophthalmic solution in the conjunctival allergen challenge model","volume":"23","author":"Spangler","year":"2001","journal-title":"Clinical Therapeutics"},{"issue":"7","key":"10.1016\/j.clae.2011.08.009_bib0525","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1016\/S0149-2918(00)80055-7","article-title":"A comparison of the relative efficacy and clinical performance of olopatadine hydrochloride ophthalmic solution 0.1% and ketotifen fumarate 0.025% ophthalmic solution in the conjunctival allergen challenge model","volume":"22","author":"Berdy","year":"2000","journal-title":"Clinical Therapeutics"},{"issue":"12","key":"10.1016\/j.clae.2011.08.009_bib0530","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.1185\/030079904X5724","article-title":"Comparative efficacy of olopatadine 0.1% ophthalmic solution versus levocabastine 0.05% ophthalmic suspension using the allergen challenge model","volume":"20","author":"Abelson","year":"2004","journal-title":"Current Medical Research and Opinion"},{"issue":"2","key":"10.1016\/j.clae.2011.08.009_bib107","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/S0011-393X(04)90032-X","article-title":"Double masked, randomised, parallel-group study comparing olopatadine 0.1% ophthalmic solution with cromolyn sodium 2% and levocabastine 0.05% ophthalmic preparations in children with seasonal allergic conjunctivitis","volume":"65","author":"Ciprandi","year":"2004","journal-title":"Current Therapeutic Research"},{"issue":"3","key":"10.1016\/j.clae.2011.08.009_bib0540","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1007\/BF02853155","article-title":"Efficacy and acceptability on nedocromil sodium 2% and olopatadine hydrochloride 0.1% in perennial allergic conjunctivitis","volume":"17","author":"Alexander","year":"2000","journal-title":"Advances in Therapy"},{"issue":"3","key":"10.1016\/j.clae.2011.08.009_bib0545","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/S0149-2918(02)85042-1","article-title":"Randomised, double-masked, placebo-controlled comparison of the efficacy of emedastine difumarate 0.05% ophthalmic solution and ketotifen fumarate 0.025% ophthalmic solution in the conjunctival challenge model","volume":"24","author":"D\u2019Arienzo","year":"2002","journal-title":"Clinical Therapeutics"},{"issue":"5","key":"10.1016\/j.clae.2011.08.009_bib0550","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1177\/112067211002000501","article-title":"Treatment of allergic conjunctivitis: results of a 1-month, single-masked randomized study","volume":"20","author":"Figus","year":"2010","journal-title":"European Journal of Ophthalmology"},{"issue":"5","key":"10.1016\/j.clae.2011.08.009_bib0555","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1097\/ACI.0b013e32830e6b29","article-title":"Evidence-based study design in ocular allergy trials","volume":"8","author":"Katelaris","year":"2008","journal-title":"Current Opinion in Allergy and Clinical Immunology"}],"container-title":["Contact Lens and Anterior Eye"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S136704841100124X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S136704841100124X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,6,15]],"date-time":"2019-06-15T17:12:41Z","timestamp":1560618761000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S136704841100124X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,2]]},"references-count":111,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,2]]}},"alternative-id":["S136704841100124X"],"URL":"https:\/\/doi.org\/10.1016\/j.clae.2011.08.009","relation":{},"ISSN":["1367-0484"],"issn-type":[{"value":"1367-0484","type":"print"}],"subject":[],"published":{"date-parts":[[2012,2]]}}}